Innovating Works

ANOCCA

Desconocido
RTCure: Rheuma Tolerance for Cure ANOCCA AB participó en un H2020 H2020-JTI-IMI2-2016-09-two-stage In line with IMI2 goals for improved therapies and precision medicine, the aim of this proposal is to prevent and treat RA or its progressio...
2017-08-25 - 2023-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.